TG Therapeutics | TGTX - Gross Profit On Sales

Stock Price
28.86
Daily Change
1.10 3.96%
Monthly
-4.88%
Yearly
-12.78%
Q1 Forecast
28.52

TG Therapeutics reported $133.62M in Gross Profit on Sales for its fiscal quarter ending in September of 2025.





Gross Profit On Sales Change Date
AbbVie USD 10.47B 605M Sep/2025
Alaunos Therapeutics USD -1.13M 1.11M Sep/2024
Amgen USD 6.48B 307M Sep/2025
Ardelyx USD 106.35M 23.51M Sep/2025
Arrowhead Research USD 256.47M 228.7M Sep/2025
Bayer EUR 5.35B 1.02B Sep/2025
Biogen USD 1.65B 34.6M Dec/2025
Corcept Therapeutics USD 203.04M 12.04M Sep/2025
Dynavax Technologies USD 78.57M 24.17M Jun/2025
Gilead Sciences USD 5.58B 453M Jun/2025
J&J USD 16.6B 118M Dec/2025
Novartis USD 10.82B 695M Sep/2025
PTC Therapeutics USD 187.69M 24.3M Sep/2025
Regeneron Pharmaceuticals USD 3.3B 67M Dec/2025
Roche Holding CHF 22.09B 10.04B Dec/2025
TG Therapeutics USD 133.62M 11.41M Sep/2025
Vertex Pharmaceuticals USD 2.66B 104.4M Sep/2025